Feb. 6 at 1:20 AM
Commercial-stage bio share price changes last 2 days while the XBI lost 5.4%. Peak to low, the XBI was off 7%+. Read our earlier post today. 18 of the 23 in this peer group were down
$URGN was the best performing bio in th peer group. There was no news nor SEC filing outside of announcing URGN will be presenting of the Guggenheim investor event. URGN hit
$30 per share around Thanksgiving so Ms. Barrett has a way to go.
$LEGN is off 40% since J&J presented their data at ASH, almost going down at a straight 45 degree angle the last 2 months. The fact that LEGN's share price held steady during the worst 2 days in the XBI could mean nothing but perhaps?
$INCY held firm as well. INCY is the first in this peer group to report next Tuesday. We're certainly hoping they announce a SNDX acquisition Monday morning (but have no reason to suspect they will).
$ADCT We have no idea why ADCT held firm after more than doubling the last 8 months.
$JAZZ Research Ziihera's potential for yourself
Non is next
FWIW
